Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05766501 |
|---|---|
| Brief Title: | A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054) |
| First Submitted : | March 1, 2023 |
| First Submitted that Met QC Criteria : | March 1, 2023 |
| First Posted : | March 13, 2023 |
| Last Update Submitted that Met QC Criteria : | January 3, 2024 |
| Last Update Posted : | January 5, 2024 |